These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

906 related articles for article (PubMed ID: 23103355)

  • 1. Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators.
    Brown I; Cascio MG; Rotondo D; Pertwee RG; Heys SD; Wahle KW
    Prog Lipid Res; 2013 Jan; 52(1):80-109. PubMed ID: 23103355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells.
    Chiba T; Ueno S; Obara Y; Nakahata N
    J Pharm Pharmacol; 2011 May; 63(5):636-47. PubMed ID: 21492165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endocannabinoids anandamide and virodhamine modulate the activity of the candidate cannabinoid receptor GPR55.
    Sharir H; Console-Bram L; Mundy C; Popoff SN; Kapur A; Abood ME
    J Neuroimmune Pharmacol; 2012 Dec; 7(4):856-65. PubMed ID: 22454039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis, cannabinoid receptors, and endocannabinoid system: yesterday, today, and tomorrow.
    Wu J
    Acta Pharmacol Sin; 2019 Mar; 40(3):297-299. PubMed ID: 30670816
    [No Abstract]   [Full Text] [Related]  

  • 5. Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-kappaB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation.
    Do Y; McKallip RJ; Nagarkatti M; Nagarkatti PS
    J Immunol; 2004 Aug; 173(4):2373-82. PubMed ID: 15294950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoids biology: the search for new therapeutic targets.
    Felder CC; Dickason-Chesterfield AK; Moore SA
    Mol Interv; 2006 Jun; 6(3):149-61. PubMed ID: 16809476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocannabinoids and Their Pharmacological Actions.
    Pertwee RG
    Handb Exp Pharmacol; 2015; 231():1-37. PubMed ID: 26408156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoids, endocannabinoids, and cancer.
    Hermanson DJ; Marnett LJ
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):599-612. PubMed ID: 22038019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unveiling the mechanism of action behind the anti-cancer properties of cannabinoids in ER
    Amaral C; Trouille FM; Almeida CF; Correia-da-Silva G; Teixeira N
    J Steroid Biochem Mol Biol; 2021 Jun; 210():105876. PubMed ID: 33722705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocannabinoids and Cancer.
    Velasco G; Sánchez C; Guzmán M
    Handb Exp Pharmacol; 2015; 231():449-72. PubMed ID: 26408171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand activation of cannabinoid receptors attenuates hypertrophy of neonatal rat cardiomyocytes.
    Lu Y; Akinwumi BC; Shao Z; Anderson HD
    J Cardiovasc Pharmacol; 2014 Nov; 64(5):420-30. PubMed ID: 24979612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of platelets by the endocannabinoids 2-arachidonoylglycerol and virodhamine is mediated by their conversion to arachidonic acid and thromboxane A2, not by activation of cannabinoid receptors.
    Brantl SA; Khandoga AL; Siess W
    Platelets; 2014; 25(6):465-6. PubMed ID: 24102401
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of leukocyte function and interleukin-2 gene expression by 2-methylarachidonyl-(2'-fluoroethyl)amide, a stable congener of the endogenous cannabinoid receptor ligand anandamide.
    Kaplan BL; Ouyang Y; Herring A; Yea SS; Razdan R; Kaminski NE
    Toxicol Appl Pharmacol; 2005 Jun; 205(2):107-15. PubMed ID: 15893538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed signals: cannabinoid system offers new therapeutic possibilities as well as challenges.
    Shekhar C
    Chem Biol; 2011 May; 18(5):553-4. PubMed ID: 21609833
    [No Abstract]   [Full Text] [Related]  

  • 15. Cannabinoid signaling in health and disease.
    Lu Y; Anderson HD
    Can J Physiol Pharmacol; 2017 Apr; 95(4):311-327. PubMed ID: 28263083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
    Melck D; De Petrocellis L; Orlando P; Bisogno T; Laezza C; Bifulco M; Di Marzo V
    Endocrinology; 2000 Jan; 141(1):118-26. PubMed ID: 10614630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.
    Davis MP
    Expert Opin Investig Drugs; 2014 Aug; 23(8):1123-40. PubMed ID: 24836296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anandamide-induced endoplasmic reticulum stress and apoptosis are mediated by oxidative stress in non-melanoma skin cancer: Receptor-independent endocannabinoid signaling.
    Soliman E; Van Dross R
    Mol Carcinog; 2016 Nov; 55(11):1807-1821. PubMed ID: 26513129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anandamide: an update.
    Smita K; Sushil Kumar V; Premendran JS
    Fundam Clin Pharmacol; 2007 Feb; 21(1):1-8. PubMed ID: 17227440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocannabinoids: new targets for drug development.
    Di Marzo ; Bisogno T; De Petrocellis L
    Curr Pharm Des; 2000 Sep; 6(13):1361-80. PubMed ID: 10903398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.